ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

119
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
Refresh
Company Event01 Aug 2024 20:30 • Upcoming
Add To Calendar
Company Event14 Jun 2024 22:30 • Latest
Company Event02 May 2024 20:30
Company Event02 Feb 2024 21:30
Company Event14 Dec 2023 21:30
x